A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients

Rationale: Effective targeting therapies are limited in Hepatocellular carcinoma (HCC) clinic. Characterization of tumor suppressor genes (TSGs) and elucidation their signaling cascades could shed light on new strategies for developing targeting therapies for HCC. Methods: We checked genome-wide DNA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Lu, Feng, Zhou, Qian, Liu, Lu, Zeng, Guandi, Ci, Weimin, Liu, Wanting, Zhang, Gong, Zhang, Zhiyi, Wang, Peng, Zhang, Aiqun, Gao, Yunfei, Yu, Lei, He, Qingyu, Chen, Liang
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929984/
https://ncbi.nlm.nih.gov/pubmed/31903133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados